T1	Intervention 625 758	bevacizumab plus 5-FU, leucovorin and oxaliplatin (Folfox-4) followed with bevacizumab-5-FU-RT before total mesorectal excision (TME)
T2	Intervention 793 823	bevacizumab-5-FU-RT before TME
